2
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Spasmodic torticollis and other idiopathic torsion dystonias

Medical management

Pages 139-146 | Published online: 16 May 2016

References

  • Lal S. Pathophysiology and pharmacotherapy of spasmodic torticollis: a review. Can J Neurol Sci 1979: 6(4): 427–35
  • Marsden CD. Treatment of torsion dystonia. In: Barbeau A, ed. Disorders of movement. New York, JB Lippincott, 1981: 81–104
  • Meares R. Natural history of spasmodic torticollis, and effect of surgery. Lancet 1971: 2(17 Jul): 149–50
  • Lal S, Hoyte K, Kiely ME, et al. Neuropharmacological investigation and treatment of spasmodic torticollis. Adv Neurol 1979: 24: 335–51
  • Gilbert GJ. The medical treatment of spasmodic torticollis. Arch Neurol 1972: 27(Dec): 503–6
  • Fahn S. High dosage anticholinergic therapy in dystonia. Neurology (NY) 1983: 33(10): 1255–61
  • Lang AE, Sheehy MP, Marsden CD. Acute anticholinergic action in focal dystonia. Adv Neurol 1983: 37: 193–209
  • Bianchine JR, Bianchine JW. Treatment of spasmodic torticollis with diazepam. South Med J 1971: 64(Jul): 893–4
  • Ziegler DK. Prolonged relief of dystonic movements with diazepam. Neurology 1981: 31(11): 1457–8
  • Korein J, Lieberman A, Kupersmith M, et al. Effect of L-glutamine and isoniazid on torticollis and segmental dystonia. Ann Neurol 1981: 10(3): 247–50
  • Tolosa E. Modification of tardive dyskinesia and spasmodic torticollis by apomorphine: possible role of dopamine autoreceptors. Arch Neurol 1978: 35(7): 459–62
  • Coleman M. Preliminary remarks on the L-dopa therapy of dystonia. Neurology (Minneap) 1970: 20(Nov): 114–21
  • Chase TN. Biochemical and pharmacologic studies of dystonia. Neurology (Minneap) 1970: 20(Nov): 122–30
  • Ansari KA, Webster D, Manning N. Spasmodic torticollis and L-dopa results of therapeutic trial in six patients. Neurology (Minneap) 1972: 22(Jul): 670–4
  • Barrett RE, Yahr MD, Duvoisin RC. Torsion dystonia and spasmodic torticollis—results of treatment with L-dopa. Neurology (Minneap) 1970: 20(Nov): 107–13
  • Stahl SM, Berger PA. Bromocriptine, physostigmine. and neurotransmitter mechanisms in the dystonias. Neurology (NY) 1982: 32(8): 889–92
  • Lees A, Shaw KM, Stern GM. Bromocriptine and spasmodic torticollis. (Letter] Br Med J 1976: 1(6021): 1343
  • Tanner CM, Goetz CG, Glantz RH, et al. Cholinergic mechanisms in idiopathic partial and segmental dystonias. (Abstr) Ann Neurol 1981: 10(1): 94
  • Shaw KM, Hunter KR, Stern GM. Medical treatment of spasmodic torticollis. Lancet 1972: 1(24 Jun): 1399
  • Couch JR. General discussion on drug therapy in dystonia. Adv Neurol 1976: 14: 417–22
  • Markham CH, Clark WG, Winters WD. Effect of alpha-methyl DOPA and reserpine in Huntington's chorea. Parkinson's disease and other movement disorders. Life Sci 1963: 9(Sep): 697–705
  • Gildenberg PL. Comprehensive management of spasmodic torticollis. Appl Neurophysiol 1981: 44(4): 233–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.